Use of interferons in secondary progressive forms of multiple sclerosis. Efficacy, safety and quality of life of patients treated with these therapies

Authors
Category Systematic review
JournalJournal of the Neurological Sciences
Year 2023
This article has no abstract
Epistemonikos ID: c394da589b6876ddc27c0001c582fd5666c8ebdd
First added on: Feb 17, 2025